A look at the weighted underlying holdings of the First Trust Value Line 100 Exchange-Traded Fund (FVL) shows an impressive 13.2% of holdings on a weighted basis have experienced insider buying within the past six months.

START SLIDESHOW:
10 ETFs With Stocks That Insiders Are Buying »

Daktronics Inc. ( DAKT - Get Report), which makes up 1.16% of the First Trust Value Line 100 Exchange-Traded Fund (FVL), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $591,979 worth of DAKT, making it the #7 largest holding. The table below details the recent insider buying activity observed at DAKT:

DAKT — last trade: $10.48 — Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
06/23/2016 Kevin Patrick McDermott Director 3,900 $6.48 $25,272
06/28/2016 Reece A. Kurtenbach Chairman, President and CEO 10,000 $6.20 $62,048
07/05/2016 Kevin Patrick McDermott Director 2,000 $6.10 $12,200

And Meridian Bioscience Inc. ( VIVO), the #67 largest holding among components of the First Trust Value Line 100 Exchange-Traded Fund (FVL), shows 4 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $515,659 worth of VIVO, which represents approximately 1.01% of the ETF's total assets at last check. The recent insider buying activity observed at VIVO is detailed in the table below:

VIVO — last trade: $17.35 — Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
08/11/2016 John McIlwraith Director 1,000 $19.57 $19,565
11/04/2016 John A. Kraeutler Chairman and CEO 5,000 $16.13 $80,666
11/03/2016 Lawrence Baldini EVP, Pres Global Operations 4,900 $16.00 $78,400
11/30/2016 Dwight E. Ellingwood Director 1,020 $17.12 $17,466